External quality assurance programme for newborn screening of glucose-6-phosphate dehydrogenase deficiency

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 12 SUPPL., 2008, Pages 84-87

  Chiang, Szu Hui ^a   Fan, Mei Ling ^a   Hsiao, Kwang Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Preventive Medicine Foundation   (Taiwan)

Author keywords

External quality assurance; Glucose 6 Phosphate Dehydrogenase; Newborn Screening

Indexed keywords

ARTICLE; CLINICAL TRIAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE QUALITY; HUMAN; MULTICENTER STUDY; NEWBORN; NEWBORN SCREENING; STANDARD;

GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; QUALITY ASSURANCE, HEALTH CARE;

EID: 84873476165     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. th ed. New York: McGraw-Hill, 2001.
2. World Health Organization Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull WHO 1989;67:601-11.
3. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 2008;111:16-24.
4. Chen SH, Lin KS, Lee TY, Chen CL. Glucose-6-phosphate dehydrogenase deficiency and neonatal hyperbilirubinemia in Chinese. Acta Paediatr Sinica 1986;27:286-93.
5. Yu MW, Hsiao KJ, Wuu KD, Chen CJ. Association between glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice: interaction with multiple risk factors. Int J Epidemiol 1992;21:947-52.
6. Hsiao KJ, Wuu KD. Neonatal screening for inborn metabolic diseases: the experience in Taiwan. In: Lin HJ, Swaminathan R, Robertshaw AM, editors. Proceedings of the 4th Asian-Pacific Congress of Clinical Biochemistry. Hong Kong: Gardiner-Caldwell, 1989:214-8.
7. Hsiao KJ. Genetic disorders and neonatal screening. In: Myai K, Kanno T, Ishikawa E, editors. Progress in Clinical Biochemistry. Amsterdam: Elsevier Science, 1992:289-92.
8. Hsiao KJ, Chiang SH. Developments of Neonatal Screening in Taiwan. International Conference on Genetic Medicine and Promoting Healthcare for Rare Disorder, Taipei, 2005:255-8.
9. Hsiao KJ. Neonatal Screening of Glucose-6-Phosphate Dehydrogenase Deficiency. 2nd Congress of Asian Society for Pediatric Research, Yokohama, 2006:74.
10. Chiang SH, Wu SJ, Wu KF, Hsiao KJ. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan. Southeast Asian J Trop Med Public Health 1999;30Suppl2:72-4.
11. Hsiao KJ, Chiang SH. Interlaboratory quality assurance program for determination of blood glucose-6-phosphate dehydrogenase activity: experience in Taiwan. In: Ohba Y, Kanno T, Okabe H, editors. Quality Control in the Clinical Laboratory 95. Tokyo: Excerpta Medica, 1995:241-6.
12. Chiang SH, Wu KF, Liu TT, Wu SJ, Hsiao KJ. Quality assurance program for neonatal screening of glucose-6phosphate dehydrogenase deficiency. Southeast Asian J Trop Med Public Health 2003; 34Suppl3:130-4.
13. Deutsch J. Maleimide as an inhibitor in measurement of erythrocyte glucose-6-phosphate dehydrogenase activity. Clin Chem 1978;24,885-9.